{
    "organizations": [],
    "uuid": "6bedf978e62c67bc0891ad6671784500a6b94d6a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-sucampo-pharmaceuticals-received-n/brief-sucampo-pharmaceuticals-received-notification-from-fda-that-it-has-extended-pdufa-goal-date-by-3-months-idUSFWN1OX0HR",
    "ord_in_thread": 0,
    "title": "BRIEF-Sucampo Pharmaceuticals Received Notification From FDA That It Has Extended PDUFA Goal Date By 3 Months",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 36 PM / Updated 5 minutes ago BRIEF-Sucampo Pharmaceuticals Received Notification From FDA That It Has Extended PDUFA Goal Date By 3 Months Reuters Staff 1 Min Read \nJan 2 (Reuters) - Sucampo Pharmaceuticals Inc: \n* SUCAMPO PHARMACEUTICALS - ON DEC 28, RECEIVED NOTIFICATION FROM U.S. FDA THAT IT HAS EXTENDED PDUFA GOAL DATE BY 3 MONTHS FOR SNDA FOR LUBIPROSTONE \n* SUCAMPO PHARMACEUTICALS - EXTENDED USER FEE GOAL DATE FOR THE SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) FOR LUBIPROSTONE IS APRIL 28, 2018- SEC FILING Source text :[ bit.ly/2Ctygjm ] Further company coverage:",
    "published": "2018-01-02T16:36:00.000+02:00",
    "crawled": "2018-01-02T16:43:11.039+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "received",
        "notification",
        "fda",
        "extended",
        "pdufa",
        "goal",
        "date",
        "month",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "sucampo",
        "pharmaceutical",
        "inc",
        "sucampo",
        "pharmaceutical",
        "dec",
        "received",
        "notification",
        "fda",
        "extended",
        "pdufa",
        "goal",
        "date",
        "month",
        "snda",
        "lubiprostone",
        "sucampo",
        "pharmaceutical",
        "extended",
        "user",
        "fee",
        "goal",
        "date",
        "supplemental",
        "new",
        "drug",
        "application",
        "snda",
        "lubiprostone",
        "april",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}